Ultragenyx Pharmaceutical shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Ultragenyx Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including Ultragenyx Pharmaceutical held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ultragenyx Pharmaceutical by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $9.8M | 325k | 30.08 |
| 2025-06-30 | $17M | 474k | 36.36 |
| 2025-03-31 | $25M | 696k | 36.21 |
| 2024-12-31 | $31M | 739k | 42.07 |
| 2024-09-30 | $43M | 772k | 55.55 |
| 2024-06-30 | $32M | 782k | 41.10 |
| 2024-03-31 | $43M | 912k | 46.69 |
| 2023-12-31 | $48M | 1.0M | 47.82 |
| 2023-09-30 | $22M | 622k | 35.65 |
| 2023-06-30 | $30M | 643k | 46.13 |
| 2023-03-31 | $26M | 652k | 40.10 |
| 2022-12-31 | $30M | 652k | 46.33 |
| 2022-09-30 | $46M | 736k | 62.50 |
| 2022-06-30 | $47M | 794k | 59.67 |
| 2022-03-31 | $55M | 755k | 73.03 |
| 2021-12-31 | $70M | 850k | 82.57 |
| 2021-09-30 | $78M | 864k | 90.19 |
| 2021-06-30 | $82M | 860k | 95.35 |
| 2021-03-31 | $94M | 822k | 113.86 |
| 2020-12-31 | $105M | 759k | 138.43 |
| 2020-09-30 | $64M | 772k | 82.19 |
| 2020-06-30 | $59M | 755k | 78.65 |
| 2020-03-31 | $31M | 704k | 44.43 |
| 2019-12-31 | $9.9M | 231k | 42.71 |
| 2019-09-30 | $9.7M | 226k | 42.78 |
| 2019-06-30 | $15M | 228k | 63.50 |
| 2019-03-31 | $16M | 229k | 69.36 |
| 2018-12-31 | $9.0M | 208k | 43.48 |
| 2018-09-30 | $16M | 207k | 76.34 |
| 2018-06-30 | $16M | 208k | 76.87 |
| 2018-03-31 | $10M | 204k | 50.99 |
| 2017-12-31 | $8.1M | 176k | 46.39 |
| 2017-06-30 | $11M | 176k | 62.11 |
| 2017-03-31 | $13M | 186k | 67.77 |
| 2016-12-31 | $12M | 175k | 70.32 |
| 2016-09-30 | $12M | 165k | 70.93 |
| 2016-06-30 | $8.4M | 171k | 48.90 |